These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 4124890)

  • 21. Lignocaine in the management of ventricular arrhythmias.
    Anderson ST; Pitt A
    Med J Aust; 1969 Feb; 1(5):208-11. PubMed ID: 4180672
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of KO 1173, a new antiarrhythmic drug, on contractile state of diseased left ventricle and on frequency of 'stable' premature beats.
    Shaw TR; Royds R
    Br Heart J; 1973 May; 35(5):558. PubMed ID: 4716039
    [No Abstract]   [Full Text] [Related]  

  • 23. The development of mexiletine in the management of ventricular dysrhythmias.
    Campbell NP; Chaturvedi NC; Shanks RG; Kelly JG; Strong JE; Adgey AA
    Postgrad Med J; 1977; 53 Suppl 1():114-9. PubMed ID: 69297
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of the efficacy and tolerance of the antiarrhythmic agent transcainide (R 54718).
    Stroobandt R; Bennett PB; Hondeghem LM; Kesteloot H
    Eur J Clin Pharmacol; 1987; 32(5):449-56. PubMed ID: 2441995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
    Sami M; Lisbona R
    Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia.
    Horowitz LN; Greenspan AM; Spielman SR; Frye SJ; Yacone LA; Lowenthal DT
    Clin Pharmacol Ther; 1985 Jun; 37(6):644-8. PubMed ID: 2408808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
    G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of aprindine on ventricular arrhthmias].
    Domínguez JF; Martín Sánchez JC; Ciscar A; Hidalgo M; Petit Guinovart M; Ballesta Barcons F
    Rev Esp Cardiol; 1975; 38(2):145-52. PubMed ID: 49071
    [No Abstract]   [Full Text] [Related]  

  • 29. [Causes and treatment of ventricular arrhythmias].
    Kappenberger L
    Schweiz Med Wochenschr; 1990 Jun; 120(25):941-5. PubMed ID: 1695020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Méxiletine. Action on heart rhythm disorders].
    Lellouche D; Bougherbal R
    Nouv Presse Med; 1975 Feb; 4(5):351-2. PubMed ID: 1093125
    [No Abstract]   [Full Text] [Related]  

  • 31. [What is safe in the therapy of tachycardic heart arrhythmias?].
    Wehr M; Noll B; Krappe J
    Internist (Berl); 1985 Dec; 26(12):741-9. PubMed ID: 2417980
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Mahapatra RK; Mahapatra D
    Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tocainide and mexiletine. Orally effective lidocaine analogues.
    Roden DM
    Arch Intern Med; 1985 Mar; 145(3):417-8. PubMed ID: 3919665
    [No Abstract]   [Full Text] [Related]  

  • 35. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tactics of treatment of patients with arrhythmia].
    Glezer MG; Orlov LL
    Klin Med (Mosk); 1995; 73(4):13-7. PubMed ID: 7474808
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B
    Clin Ter; 1983 Apr; 105(1):3-11. PubMed ID: 6189663
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD; Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1972 Aug; 45(4):561-73. PubMed ID: 5085230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practolol--an analysis of clinical trials in cardiac dysrhythmias.
    Wiseman RA
    Acta Cardiol; 1972; Suppl 16():19-28. PubMed ID: 4119921
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of cardiac arrhythmias in the aged].
    Stazi C; Stazi F
    Clin Ter; 1989 Mar; 128(5):329-41. PubMed ID: 2470546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.